| 1 |
35335853 | Towards the Elucidation of the Pharmacokinetics of Voriconazole: A Quantitative Characterization of Its Metabolism. | 2022 Feb 22 |
1 |
| 2 |
27853934 | Evaluation of In Vitro Cytochrome P450 Inhibition and In Vitro Fate of Structurally Diverse N-Oxide Metabolites: Case Studies with Clozapine, Levofloxacin, Roflumilast, Voriconazole and Zopiclone. | 2017 Aug |
1 |
| 3 |
28370390 | Autoinhibitory properties of the parent but not of the N-oxide metabolite contribute to infusion rate-dependent voriconazole pharmacokinetics. | 2017 Sep |
1 |
| 4 |
28834922 | Relationship Between the CYP2C19 Phenotype Using the Voriconazole-to-Voriconazole N-Oxide Plasma Concentration Ratio and Demographic and Clinical Characteristics of Japanese Patients With Different CYP2C19 Genotypes. | 2017 Oct |
1 |
| 5 |
23766489 | Steady-state pharmacokinetics and metabolism of voriconazole in patients. | 2013 Nov |
1 |